D-Cateslytin: a new antifungal agent for the treatment of oral Candida albicans associated infections
Abstract The excessive use of antifungal agents, compounded by the shortage of new drugs being introduced into the market, is causing the accumulation of multi-resistance phenotypes in many fungal strains. Consequently, new alternative molecules to conventional antifungal agents are urgently needed...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2018-06-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-018-27417-x |